Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Tungshun Pharmaceutical is a comprehensive pharmaceutical enterprise based in Xiangyang, Hubei Province, China. The company specializes in the research, development, manufacturing, and distribution of chemical drugs and traditional Chinese medicines (TCM). Its product portfolio covers several major therapeutic areas, including cardiovascular health, respiratory ailments, and digestive disorders. Hubei Tungshun operates modern production facilities that are fully GMP-certified, producing various dosage forms such as tablets, capsules, and granules. The company is a significant player in the regional Chinese pharmaceutical market, focusing on providing high-quality and affordable medicinal products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Tungshun Pharmaceutical.